Related Experiment Video
Updated: Jul 3, 2026

Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis
Surmeet Bedi1, Aparna Vidyasagar, Arjang Djamali
1Department of Medicine, Nephrology Section, University of Wisconsin Madison School of Medicine and Public Health, Madison, WI 53713, USA.
Abstract:
Chronic allograft tubular atrophy/interstitial fibrosis (TA/IF) is a major cause of late allograft loss. A major challenge to the future of kidney transplantation is to dissect the identifiable causes of chronic allograft TA/IF and to develop cause-specific treatment strategies. Emerging evidence suggests that epithelial-to-mesenchymal transition (EMT) is an important event in native and transplant kidney injury, including chronic allograft TA/IF. During EMT, tubular epithelial cells are transformed into myofibroblasts through a stepwise process including loss of cell-cell adhesion and E-cadherin expression, de novo alpha-smooth muscle actin expression, actin reorganization, tubular basement membrane disruption, cell migration, and fibroblast invasion with production of profibrotic molecules such as collagen types I and III and fibronectin. We examined in this review the molecular and cellular pathways of EMT and their involvement in chronic allograft tubulointerstitial fibrosis. We examined the role of alloimmune T cells and oxidative stress in this context and evaluated EMT as a marker of disease progression. Potential therapeutic options are discussed. In conclusion, there is enough evidence demonstrating that EMT is involved in the pathogenesis of chronic allograft tubulointerstitial fibrosis. However, the extent of its contribution to allograft fibrogenesis remains unknown, and only interventional trials will enable us to clarify this question. Furthermore, additional data are required to determine whether EMT may be used as a surrogate marker of disease progression in kidney transplant recipients.
Insights
Epithelial-to-mesenchymal transition (EMT) drives chronic kidney transplant fibrosis. Further research is needed to confirm EMT
Area of Science:
- Nephrology
- Transplantation Immunology
- Cell Biology
Background:
- Chronic allograft tubular atrophy/interstitial fibrosis (TA/IF) significantly contributes to late kidney allograft loss.
- Identifying causes and developing targeted treatments for TA/IF are critical for advancing kidney transplantation.
- Epithelial-to-mesenchymal transition (EMT) is increasingly recognized as a key process in kidney injury, including chronic allograft TA/IF.
Purpose of the Study:
- To review the molecular and cellular pathways of EMT in the context of chronic allograft tubulointerstitial fibrosis.
- To examine the roles of alloimmune T cells and oxidative stress in EMT-driven fibrosis.
- To evaluate the potential of EMT as a marker for disease progression and discuss therapeutic strategies.
Main Methods:
- Literature review focusing on molecular and cellular mechanisms of EMT in kidney allografts.
- Analysis of studies investigating the influence of alloimmunity and oxidative stress on EMT.
- Evaluation of existing data on EMT as a disease marker and therapeutic target.
Main Results:
- EMT involves tubular epithelial cells transforming into myofibroblasts via loss of cell adhesion, altered gene expression (e.g., E-cadherin, alpha-smooth muscle actin), and extracellular matrix production.
- Alloimmune T cells and oxidative stress are implicated in promoting EMT in kidney allografts.
- EMT is demonstrably involved in the pathogenesis of chronic allograft tubulointerstitial fibrosis.
Conclusions:
- EMT plays a significant role in the development of chronic allograft tubulointerstitial fibrosis.
- The precise contribution of EMT to allograft fibrogenesis requires further investigation through interventional trials.
- Additional research is necessary to validate EMT as a reliable surrogate marker for disease progression in kidney transplant recipients.
More Related Videos
06:02Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
Published on: June 10, 2016
07:11Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Related Concept Videos
Chronic Inflammation: Introduction
Acute Kidney Injury II: Pathophysiology
Diabetic Nephropathy
Cirrhosis II: Pathophysiology
Nephrotic Syndrome I : Introduction
Kidney Transplant II: Surgical Procedure